Should I Buy ICMB? ICMB 2026 Analysis

Should You Buy Investcorp Credit Management BDC Inc (ICMB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

2.830

1 Day change

2.54%

52 Week Range

3.470

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient trader: no proprietary buy signals, weak recent fundamentals, and options positioning is heavily put-skewed.
Short-term technicals are only mildly constructive (near pivot with neutral RSI), but upside looks capped near ~3.00–3.07 unless earnings delivers a catalyst.
With earnings on 2026-02-11 (after hours), risk/reward today is unfavorable for immediate entry; better treated as a wait/hold rather than a chase-buy.

Technical Analysis

Price context: last close ~2.95, sitting just above the pivot (2.887); near-term trend is more “stabilizing” than strongly bullish.
MACD: histogram positive (0.0138) but contracting → bullish momentum exists but is fading.
RSI(6) at 55.36 → neutral-to-slightly bullish, no overbought/oversold edge.
Moving averages: converging → consolidation/indecision, often precedes a larger move but direction not confirmed.
Key levels: Support S1 2.772 (then S2 2.702); Resistance R1 3.002 (then R2 3.072). A clean break above ~3.00 is needed to justify a momentum-style buy.
Pattern-based forward odds: ~60% chance of a slightly negative next day (-0.11%), but statistical bias points to positive 1-week (+6.06%) and 1-month (+9.23%)—suggesting potential swing upside, not a clear immediate entry trigger today.

Options Data

Bearish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment/positioning: Open interest put-call ratio is extremely high (11.89) → market positioning skews defensive/bearish (or heavy hedging).
Liquidity: today’s option volume is 0 → options tape provides weak real-time confirmation; signal quality is limited.
Volatility: 30D IV ~106.79% vs historical vol ~26.02% → options are pricing very large moves; elevated event risk into earnings.
IV trend: 5D/10D avg IV (~149–152) higher than current, implying IV has been coming down, but remains very high overall.
Net read: bearish skew + illiquidity + very high IV = not supportive for a “buy right now” decision.

Technical Summary

Sell

Buy

Positive Catalysts

with nearby resistance at ~3.00; a breakout could invite quick upside momentum.

Neutral/Negative Catalysts

shows significant deterioration: revenue down sharply YoY and net income/EPS negative.

Financial Performance

Latest quarter: 2025/Q3.
Revenue: 2,587,489 (down -62.78% YoY) → major top-line contraction.
Net income: -1,260,530 (down -152.27% YoY) → swung deeper into losses.
EPS: -0.09 (down -119.57% YoY) → profitability trend worsened materially.
Gross margin: 88.55% (down -9.35% YoY) → still high, but trending lower.
Overall: growth/profitability trends are negative heading into the next earnings event.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating changes or price target updates were provided in the dataset.
Wall Street pro/con view (based on available data only):
- Pros: potential event-driven move around earnings; technical consolidation near key levels.
- Cons: sharp YoY financial deterioration; options open-interest skew defensive; lack of supportive news/coverage signals.
Influential/political trading: No recent congress trading data available; hedge fund and insider trends listed as Neutral with no significant recent activity.

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Analyst Rating

Wall Street analysts forecast ICMB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ICMB is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy